Chengxia Kan
Impact in
-
- Diabetes Treatment and Management
Papers in
-
- Metabolism, Diabetes, and Cancer 4
- PI3K/AKT/mTOR signaling in cancer 3
-
- Diabetes Treatment and Management 6
- Co-authors
- Xiaodong Sun (43 shared papers)Ningning Hou (33 shared papers)Fang Han (26 shared papers)Kexin Zhang (25 shared papers)Junfeng Shi (11 shared papers)Yongping Liu (5 shared papers)Yanhui Ma (8 shared papers)Na Qu (6 shared papers)
- Journals
- Frontiers in Public Health (4 papers)Frontiers in Endocrinology (4 papers)Frontiers in Pharmacology (4 papers)World Journal of Diabetes (3 papers)Lipids in Health and Disease (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Chengxia Kan
39 papers receiving 508 citations
Peers
Comparison fields: 5 of 103
- Endocrinology, Diabetes and Metabolism 99
- Aging 10
- Clinical Biochemistry 37
- Neuropsychology and Physiological Psychology 7
- Physiology 85
Countries citing papers authored by Chengxia Kan
This map shows the geographic impact of Chengxia Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxia Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxia Kan more than expected).
Fields of papers citing papers by Chengxia Kan
This network shows the impact of papers produced by Chengxia Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxia Kan. The network helps show where Chengxia Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengxia Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 62 | |
| 2 | 2022 | 62 | |
| 3 | 2021 | 36 | |
| 4 | 2021 | 34 | |
| 5 | 2022 | 24 | |
| 6 | 2022 | 24 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 14 | |
| 13 | 2024 | 13 | |
| 14 | 2023 | 11 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2025 | 8 | |
| 20 | 2024 | 8 |
About Chengxia Kan
Chengxia Kan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery and Physiology, having authored 46 papers that have together received 518 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Pancreatic function and diabetes (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Diet and metabolism studies (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Advanced Glycation End Products research (3 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (99 citations), Aging (10 citations), Clinical Biochemistry (37 citations), Neuropsychology and Physiological Psychology (7 citations) and Physiology (85 citations). Chengxia Kan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaodong Sun, Ningning Hou, Fang Han, Kexin Zhang, Junfeng Shi, Yongping Liu, Yanhui Ma, Na Qu, Jingwen Zhang and Hongyan Qiu. Their work appears in journals such as Frontiers in Public Health, Frontiers in Endocrinology, Frontiers in Pharmacology, World Journal of Diabetes and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.